Amanda Antell  |  August 29, 2014

Category: Legal News

Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.

Lipitor diabetes lawsuitNew York plaintiff Mary Ann Clark is suing Pfizer Inc. for the injuries she allegedly sustained from ingesting their heart disease drug, Lipitor. Clark claims that she developed type-2 diabetes as the direct result of ingesting the medication.

Clark was diagnosed with type-2 diabetes on Aug. 4, 2005, while taking Lipitor. She had been originally prescribed Lipitor to lower her cholesterol levels. Her physician had recommended it based on Pfizer’s advertisements and other medical recommendations, she claims in her Lipitor lawsuit.

Low cholesterol levels in patients encourage a healthier and more active lifestyle, and lower their chances of suffering heart disease. Instead, Clark says she is even now more susceptible to heart disease due to her diabetic condition, along with amputation, neuropathy, blindness, and other side effects.

Ever since she was diagnosed, Clark has had to readjust her life to adhere to her new requirements of living with type-2 diabetes. She now has to take a variety of medications, undergo regular blood tests, and adhere to a strict diabetic diet.

Clark is filing this Lipitor lawsuit against Pfizer, alleging that she suffered from the Lipitor side effects type-2 diabetes. Essentially, she alleges that she was not given all the information about the Lipitor side effects at the time she was prescribed Lipitor, and could not make a reasonable decision.

Clark’s legal team states that Pfizer had the civil responsibility of warning her and other Lipitor patients of the Lipitor side effects, because they are relying on the given information. Clark insist that she never would have taken Lipitor if she had known about the possibility of type-2 diabetes.

For being allegedly responsible for manufacturing, selling, distributing, and marketing a dangerous drug, Clark is suing Pfizer. The charges include: negligence, false advertising, concealing information, and misrepresenting a product.

This Lipitor Lawsuit is Mary Ann Clark v. Pfizer Inc., Case No. 0:14-cv-03104-PJS-JSM, in the U.S. District Court for the District of Minnesota.

Overview of Lipitor Diabetes Complications

Lipitor (atorvastatin) is a cholesterol-lowering medication that is manufactured by Pfizer. It was approved by the U.S. Food and Drug Administration (FDA) in 1996, and has since become the world’s best-selling medication. Even in its first years on the market, the sales of Lipitor topped in the billions. Lipitor has become the most popular among patients and doctors for its medical purpose of lowering cholesterol, which helps millions of patients live healthier lifestyles. Despite its popularity, it has become a recent medical concern that Lipitor may be associated with type-2 diabetes.

Lipitor is a member of the statin drug family and functions in similar to calcium salt, which is commonly used to lower cholesterol. Like other members of the statin family, Lipitor works by inhibiting HMG-CoA reductase, an enzyme found in liver tissue, which is vital in the production of insulin and cholesterol management.

While Lipitor’s biological mechanism has been met with much success, medical experts suspect that it is this characteristic that may be triggering the diabetic reaction.

A study conducted at the University of Massachusetts studied this possibility, by observing 153,840 women being treated with Lipitor between 1993 to 2005, and found that more than 10,200 women had developed type-2 diabetes. The researchers concluded that postmenopausal women who stay on Lipitor for more than a year, are at an approximately 9 percent greater risk of developing type-2 diabetes.

Allegedly, Pfizer knew about these risks before the study was published, but chose not to include any indications of it until 2012. This has led to many Lipitor lawsuits filed against Pfizer around all the country, alleging product liability.

In general, Lipitor lawsuits are filed individually by each plaintiff and are not class actions.

Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or class action lawsuit is best for you. Hurry — statutes of limitations may apply.

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.


Get Help – It’s Free

Join a Free Lipitor Class Action Lawsuit Investigation

If you’re a woman who was diagnosed with type-2 diabetes while taking Lipitor, or were diagnosed with diabetes within 90 days or less of your last dose of Lipitor, you may be eligible for compensation. See if you qualify by filling out the short form below.

An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.

Oops! We could not locate your form.

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.